nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.0256	0.032	CcSEcCtD
Testolactone—Malaise—Valrubicin—urinary bladder cancer	0.0248	0.0311	CcSEcCtD
Testolactone—Discomfort—Valrubicin—urinary bladder cancer	0.0232	0.029	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.0196	0.123	CbGpPWpGaD
Testolactone—Alopecia—Mitomycin—urinary bladder cancer	0.0193	0.0241	CcSEcCtD
Testolactone—Erythema—Mitomycin—urinary bladder cancer	0.019	0.0238	CcSEcCtD
Testolactone—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0185	0.0232	CcSEcCtD
Testolactone—Pain—Carboplatin—urinary bladder cancer	0.0178	0.0223	CcSEcCtD
Testolactone—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.0176	0.0221	CcSEcCtD
Testolactone—Malaise—Mitomycin—urinary bladder cancer	0.0171	0.0214	CcSEcCtD
Testolactone—Discomfort—Mitomycin—urinary bladder cancer	0.016	0.02	CcSEcCtD
Testolactone—Oedema—Mitomycin—urinary bladder cancer	0.0155	0.0194	CcSEcCtD
Testolactone—Anorexia—Mitomycin—urinary bladder cancer	0.0148	0.0185	CcSEcCtD
Testolactone—Vomiting—Valrubicin—urinary bladder cancer	0.0143	0.0179	CcSEcCtD
Testolactone—Decreased appetite—Mitomycin—urinary bladder cancer	0.0135	0.0169	CcSEcCtD
Testolactone—Nausea—Valrubicin—urinary bladder cancer	0.0134	0.0167	CcSEcCtD
Testolactone—Pain—Mitomycin—urinary bladder cancer	0.0132	0.0166	CcSEcCtD
Testolactone—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0128	0.016	CcSEcCtD
Testolactone—Glossitis—Methotrexate—urinary bladder cancer	0.0102	0.0128	CcSEcCtD
Testolactone—Vomiting—Mitomycin—urinary bladder cancer	0.00985	0.0123	CcSEcCtD
Testolactone—Alopecia—Thiotepa—urinary bladder cancer	0.00969	0.0121	CcSEcCtD
Testolactone—Erythema—Thiotepa—urinary bladder cancer	0.00955	0.012	CcSEcCtD
Testolactone—Glossitis—Epirubicin—urinary bladder cancer	0.00954	0.0119	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00939	0.0588	CbGpPWpGaD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00927	0.058	CbGpPWpGaD
Testolactone—Nausea—Mitomycin—urinary bladder cancer	0.0092	0.0115	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—urinary bladder cancer	0.00883	0.0111	CcSEcCtD
Testolactone—Estrone—ESR2—urinary bladder cancer	0.00841	0.201	CrCbGaD
Testolactone—Alopecia—Gemcitabine—urinary bladder cancer	0.00815	0.0102	CcSEcCtD
Testolactone—Erythema—Gemcitabine—urinary bladder cancer	0.00803	0.0101	CcSEcCtD
Testolactone—Alopecia—Fluorouracil—urinary bladder cancer	0.00801	0.01	CcSEcCtD
Testolactone—Erythema—Fluorouracil—urinary bladder cancer	0.0079	0.00989	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00761	0.0477	CbGpPWpGaD
Testolactone—Alopecia—Cisplatin—urinary bladder cancer	0.0076	0.00951	CcSEcCtD
Testolactone—Erythema—Cisplatin—urinary bladder cancer	0.00748	0.00937	CcSEcCtD
Testolactone—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00745	0.00933	CcSEcCtD
Testolactone—Anorexia—Thiotepa—urinary bladder cancer	0.00743	0.0093	CcSEcCtD
Testolactone—Malaise—Gemcitabine—urinary bladder cancer	0.00724	0.00907	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00719	0.045	CbGpPWpGaD
Testolactone—Paraesthesia—Thiotepa—urinary bladder cancer	0.007	0.00876	CcSEcCtD
Testolactone—Alopecia—Etoposide—urinary bladder cancer	0.00696	0.00872	CcSEcCtD
Testolactone—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00694	0.0087	CcSEcCtD
Testolactone—Decreased appetite—Thiotepa—urinary bladder cancer	0.00677	0.00848	CcSEcCtD
Testolactone—Discomfort—Gemcitabine—urinary bladder cancer	0.00675	0.00846	CcSEcCtD
Testolactone—Malaise—Cisplatin—urinary bladder cancer	0.00675	0.00845	CcSEcCtD
Testolactone—Fluoxymesterone—ESR1—urinary bladder cancer	0.00673	0.161	CrCbGaD
Testolactone—Pain—Thiotepa—urinary bladder cancer	0.00666	0.00834	CcSEcCtD
Testolactone—Discomfort—Fluorouracil—urinary bladder cancer	0.00664	0.00832	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—ESR2—urinary bladder cancer	0.00661	0.0414	CbGpPWpGaD
Testolactone—Oedema—Gemcitabine—urinary bladder cancer	0.00655	0.00821	CcSEcCtD
Testolactone—Oedema—Fluorouracil—urinary bladder cancer	0.00644	0.00807	CcSEcCtD
Testolactone—Danazol—ESR1—urinary bladder cancer	0.00643	0.154	CrCbGaD
Testolactone—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00642	0.00804	CcSEcCtD
Testolactone—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00636	0.00797	CcSEcCtD
Testolactone—Discomfort—Cisplatin—urinary bladder cancer	0.0063	0.00788	CcSEcCtD
Testolactone—Anorexia—Gemcitabine—urinary bladder cancer	0.00625	0.00782	CcSEcCtD
Testolactone—Malaise—Etoposide—urinary bladder cancer	0.00618	0.00774	CcSEcCtD
Testolactone—Anorexia—Fluorouracil—urinary bladder cancer	0.00614	0.00769	CcSEcCtD
Testolactone—Oedema—Cisplatin—urinary bladder cancer	0.00611	0.00765	CcSEcCtD
Testolactone—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00588	0.00737	CcSEcCtD
Testolactone—Anorexia—Cisplatin—urinary bladder cancer	0.00582	0.00729	CcSEcCtD
Testolactone—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00579	0.00725	CcSEcCtD
Testolactone—Discomfort—Etoposide—urinary bladder cancer	0.00577	0.00722	CcSEcCtD
Testolactone—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0057	0.00713	CcSEcCtD
Testolactone—Pain—Gemcitabine—urinary bladder cancer	0.0056	0.00702	CcSEcCtD
Testolactone—Decreased appetite—Fluorouracil—urinary bladder cancer	0.0056	0.00701	CcSEcCtD
Testolactone—Pain—Fluorouracil—urinary bladder cancer	0.00551	0.0069	CcSEcCtD
Testolactone—Paraesthesia—Cisplatin—urinary bladder cancer	0.00549	0.00687	CcSEcCtD
Testolactone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.0054	0.00676	CcSEcCtD
Testolactone—Anorexia—Etoposide—urinary bladder cancer	0.00533	0.00668	CcSEcCtD
Testolactone—Decreased appetite—Cisplatin—urinary bladder cancer	0.00531	0.00665	CcSEcCtD
Testolactone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00531	0.00665	CcSEcCtD
Testolactone—Pain—Cisplatin—urinary bladder cancer	0.00522	0.00654	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00518	0.0324	CbGpPWpGaD
Testolactone—Estrone—ESR1—urinary bladder cancer	0.00518	0.124	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00511	0.032	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—NCOR1—urinary bladder cancer	0.0051	0.0319	CbGpPWpGaD
Testolactone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00503	0.0063	CcSEcCtD
Testolactone—Paraesthesia—Etoposide—urinary bladder cancer	0.00502	0.00629	CcSEcCtD
Testolactone—Vomiting—Thiotepa—urinary bladder cancer	0.00495	0.0062	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—NAT1—urinary bladder cancer	0.00491	0.0307	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTO2—urinary bladder cancer	0.00491	0.0307	CbGpPWpGaD
Testolactone—Decreased appetite—Etoposide—urinary bladder cancer	0.00486	0.00609	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00484	0.0303	CbGpPWpGaD
Testolactone—Pain—Etoposide—urinary bladder cancer	0.00479	0.00599	CcSEcCtD
Testolactone—Nausea—Thiotepa—urinary bladder cancer	0.00463	0.0058	CcSEcCtD
Testolactone—Feeling abnormal—Etoposide—urinary bladder cancer	0.00461	0.00578	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00449	0.0281	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00443	0.0277	CbGpPWpGaD
Testolactone—Drospirenone—PTGS2—urinary bladder cancer	0.00432	0.104	CrCbGaD
Testolactone—Alopecia—Methotrexate—urinary bladder cancer	0.00417	0.00522	CcSEcCtD
Testolactone—Vomiting—Gemcitabine—urinary bladder cancer	0.00417	0.00522	CcSEcCtD
Testolactone—Erythema—Methotrexate—urinary bladder cancer	0.00411	0.00514	CcSEcCtD
Testolactone—Vomiting—Fluorouracil—urinary bladder cancer	0.0041	0.00513	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00404	0.0253	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—ATM—urinary bladder cancer	0.00404	0.0253	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—CDK4—urinary bladder cancer	0.00403	0.0252	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00399	0.025	CbGpPWpGaD
Testolactone—Alopecia—Epirubicin—urinary bladder cancer	0.0039	0.00489	CcSEcCtD
Testolactone—Nausea—Gemcitabine—urinary bladder cancer	0.00389	0.00488	CcSEcCtD
Testolactone—Vomiting—Cisplatin—urinary bladder cancer	0.00388	0.00486	CcSEcCtD
Testolactone—Erythema—Epirubicin—urinary bladder cancer	0.00384	0.00481	CcSEcCtD
Testolactone—Nausea—Fluorouracil—urinary bladder cancer	0.00383	0.00479	CcSEcCtD
Testolactone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00381	0.00477	CcSEcCtD
Testolactone—Malaise—Methotrexate—urinary bladder cancer	0.0037	0.00464	CcSEcCtD
Testolactone—Nausea—Cisplatin—urinary bladder cancer	0.00363	0.00454	CcSEcCtD
Testolactone—Alopecia—Doxorubicin—urinary bladder cancer	0.00361	0.00452	CcSEcCtD
Testolactone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00357	0.00447	CcSEcCtD
Testolactone—Vomiting—Etoposide—urinary bladder cancer	0.00356	0.00446	CcSEcCtD
Testolactone—Erythema—Doxorubicin—urinary bladder cancer	0.00356	0.00445	CcSEcCtD
Testolactone—Malaise—Epirubicin—urinary bladder cancer	0.00347	0.00434	CcSEcCtD
Testolactone—Discomfort—Methotrexate—urinary bladder cancer	0.00345	0.00433	CcSEcCtD
Testolactone—Progesterone—ESR1—urinary bladder cancer	0.00333	0.0798	CrCbGaD
Testolactone—Nausea—Etoposide—urinary bladder cancer	0.00332	0.00416	CcSEcCtD
Testolactone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.0033	0.00413	CcSEcCtD
Testolactone—Discomfort—Epirubicin—urinary bladder cancer	0.00323	0.00405	CcSEcCtD
Testolactone—Malaise—Doxorubicin—urinary bladder cancer	0.00321	0.00402	CcSEcCtD
Testolactone—Triamcinolone—PTGS2—urinary bladder cancer	0.0032	0.0766	CrCbGaD
Testolactone—Anorexia—Methotrexate—urinary bladder cancer	0.0032	0.004	CcSEcCtD
Testolactone—Oedema—Epirubicin—urinary bladder cancer	0.00314	0.00393	CcSEcCtD
Testolactone—Paraesthesia—Methotrexate—urinary bladder cancer	0.00301	0.00377	CcSEcCtD
Testolactone—Discomfort—Doxorubicin—urinary bladder cancer	0.00299	0.00375	CcSEcCtD
Testolactone—Anorexia—Epirubicin—urinary bladder cancer	0.00299	0.00374	CcSEcCtD
Testolactone—Decreased appetite—Methotrexate—urinary bladder cancer	0.00291	0.00365	CcSEcCtD
Testolactone—Oedema—Doxorubicin—urinary bladder cancer	0.0029	0.00363	CcSEcCtD
Testolactone—Pain—Methotrexate—urinary bladder cancer	0.00287	0.00359	CcSEcCtD
Testolactone—Paraesthesia—Epirubicin—urinary bladder cancer	0.00282	0.00353	CcSEcCtD
Testolactone—Anorexia—Doxorubicin—urinary bladder cancer	0.00277	0.00346	CcSEcCtD
Testolactone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00276	0.00346	CcSEcCtD
Testolactone—Decreased appetite—Epirubicin—urinary bladder cancer	0.00273	0.00342	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—NAT2—urinary bladder cancer	0.00269	0.0168	CbGpPWpGaD
Testolactone—Pain—Epirubicin—urinary bladder cancer	0.00268	0.00336	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—SRC—urinary bladder cancer	0.00267	0.0167	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00265	0.0166	CbGpPWpGaD
Testolactone—Betamethasone—PTGS2—urinary bladder cancer	0.00262	0.0627	CrCbGaD
Testolactone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00261	0.00326	CcSEcCtD
Testolactone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00258	0.00324	CcSEcCtD
Testolactone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00252	0.00316	CcSEcCtD
Testolactone—Pain—Doxorubicin—urinary bladder cancer	0.00248	0.00311	CcSEcCtD
Testolactone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00239	0.003	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00215	0.0135	CbGpPWpGaD
Testolactone—Vomiting—Methotrexate—urinary bladder cancer	0.00213	0.00267	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00213	0.0133	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTT1—urinary bladder cancer	0.00209	0.0131	CbGpPWpGaD
Testolactone—Vomiting—Epirubicin—urinary bladder cancer	0.00199	0.0025	CcSEcCtD
Testolactone—Nausea—Methotrexate—urinary bladder cancer	0.00199	0.00249	CcSEcCtD
Testolactone—Nausea—Epirubicin—urinary bladder cancer	0.00186	0.00233	CcSEcCtD
Testolactone—Vomiting—Doxorubicin—urinary bladder cancer	0.00185	0.00231	CcSEcCtD
Testolactone—Nausea—Doxorubicin—urinary bladder cancer	0.00172	0.00216	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00155	0.00972	CbGpPWpGaD
Testolactone—Dexamethasone—PTGS2—urinary bladder cancer	0.00152	0.0365	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—GSTP1—urinary bladder cancer	0.00145	0.00905	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00143	0.00893	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—GSTM1—urinary bladder cancer	0.00133	0.00832	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00131	0.00821	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00117	0.00731	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.00116	0.00728	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00116	0.00725	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.00101	0.00633	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.00101	0.00631	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTZ1—urinary bladder cancer	0.000886	0.00555	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NAT1—urinary bladder cancer	0.00084	0.00526	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTO2—urinary bladder cancer	0.00084	0.00526	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000826	0.00517	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UGT2B7—urinary bladder cancer	0.000768	0.00481	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000751	0.0047	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000725	0.00454	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP4B1—urinary bladder cancer	0.000692	0.00433	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000692	0.00433	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC19A1—urinary bladder cancer	0.000653	0.00409	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PRSS3—urinary bladder cancer	0.000637	0.00398	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000603	0.00377	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.00059	0.00369	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000557	0.00349	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00051	0.00319	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TYMP—urinary bladder cancer	0.000509	0.00319	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000495	0.0031	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000489	0.00306	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NAT2—urinary bladder cancer	0.00046	0.00288	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—RRM2—urinary bladder cancer	0.000397	0.00249	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HPGDS—urinary bladder cancer	0.000368	0.0023	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ENO2—urinary bladder cancer	0.000368	0.0023	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000366	0.00229	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTT1—urinary bladder cancer	0.000357	0.00223	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000351	0.0022	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NQO1—urinary bladder cancer	0.000297	0.00186	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000288	0.0018	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000251	0.00157	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTP1—urinary bladder cancer	0.000247	0.00155	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000239	0.0015	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TYMS—urinary bladder cancer	0.00023	0.00144	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTM1—urinary bladder cancer	0.000227	0.00142	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOR1—urinary bladder cancer	0.000227	0.00142	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPX1—urinary bladder cancer	0.000218	0.00136	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ERCC2—urinary bladder cancer	0.000214	0.00134	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	0.000201	0.00126	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PPARG—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	0.000156	0.00098	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	0.000128	0.000802	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTEN—urinary bladder cancer	0.000112	0.0007	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—EP300—urinary bladder cancer	0.000107	0.000667	CbGpPWpGaD
